Polymalic Acid Nanoconjugates for Brain Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current imaging techniques, including MRI, face challenges in distinguishing between different pathological conditions in the brain, such as cancer types and Alzheimer's disease, due to the inability of contrast agents like gadolinium to cross the blood-brain barrier and rapid elimination through the kidneys, resulting in insufficient resolution and long exposure times.
Innovation Solution
Development of nanoconjugates comprising a polymalic acid-based molecular scaffold conjugated with imaging moieties, such as gadolinium-DOTA, and targeting modules, like monoclonal antibodies, which can specifically bind to diseased cells or tissues, enhancing permeation across the blood-brain barrier and prolonging circulation time for improved imaging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional contrast agents like gadolinium are used for MRI imaging, then imaging can be performed, but the agents cannot cross the blood-brain barrier and are rapidly eliminated through the kidneys, resulting in insufficient resolution and long exposure times
Solution Approach 1:
The patent creates a composite nanoconjugate system combining polymalic acid scaffold, gadolinium-DOTA complex, and monoclonal antibody targeting modules. This composite structure enables the contrast agent to cross the blood-brain barrier via receptor-mediated transcytosis while maintaining MRI contrast enhancement, thereby improving imaging resolution and reducing exposure time by eliminating the need for prolonged circulation.
Solution Approach 2:
The monoclonal antibody serves as an intermediary that mediates the transport of the gadolinium-DOTA complex across the blood-brain barrier through receptor-mediated transcytosis. This intermediary mechanism enables selective penetration into the brain tissue while avoiding rapid renal elimination, thus improving both imaging precision and time efficiency.
2Measurement precision
If conventional contrast agents are used, then imaging can be performed, but the agents fail to differentiate between different pathological conditions in the brain
Solution Approach 1:
The patent attaches different monoclonal antibody targeting modules to the polymalic acid scaffold, each specific for different pathological conditions (e.g., anti-amyloid beta for Alzheimer's, anti-tumor markers for cancer). This creates locally specialized imaging agents that can differentiate between various brain pathologies with high specificity, overcoming the non-specific binding of conventional gadolinium agents.
Solution Approach 2:
The imaging system is segmented into modular components: the polymalic acid scaffold, the gadolinium-DOTA contrast complex, and interchangeable monoclonal antibody targeting modules. This segmentation allows selective combination of different targeting modules to create disease-specific imaging agents, enabling precise differentiation between various pathological conditions.
3Measurement precision
If conventional imaging techniques are used, then general imaging can be obtained, but the techniques cannot clearly distinguish details of small Alzheimer's plaques or cancer types
Solution Approach 1:
The patent uses curcumin as a molecular copy or surrogate that binds to amyloid beta plaques with high affinity, serving as a detectable proxy for the plaques themselves. This copying approach enables indirect visualization of small Alzheimer's plaques that would be undetectable by direct imaging methods, improving detection precision without requiring more complex imaging equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoconjugates enable enhanced imaging of brain tumors and Alzheimer's plaques with improved resolution and retention, allowing for more accurate differentiation of pathological conditions and prolonged imaging duration compared to conventional contrast agents.
Implementation Method 1
Breakthrough imaging techniques made use of magnetic resonance imaging (MRI). MRI is one of the most advanced non-invasive imaging systems due to application of high resolution contrast agents that include gadolinium (Gd).
Implementation Method 2
enhancing permeation across the blood-brain barrier and prolonging circulation time for improved imaging
Data Source
AI summary
Nanoconjugates that include a polymalic-based molecular scaffold with one or more imaging moiety and one or more targeting modules attached to the scaffold are provided. Methods of targeting a diseased cell or a diseased tissue in a subject by administering the nanoconjugate are described. Methods of synthesizing the nanoconjugate are also provided.